Emeline Mestdach

Emeline Mestdach

Auto-generated profile, based on publicly available information

Emeline Mestdach

Centre de Résonance Magnétique Nucléaire à Très Hauts Champs, UMR 5082, CNRS, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon 1

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 October 2026 in Journal of Virology
Verified
Journal Article
Open access
SDSéraphine Degroux
Séraphine Degroux
CVCorinne Vivès
Corinne Vivès
EMEmeline Mestdach
Emeline Mestdach
CDClaudine Darnault
Claudine Darnault
ARAline le Roy
Aline le Roy
CBCécile Breyton
Cécile Breyton
Superinfection exclusion is a widespread viral mechanism that protects the infected cell from overinfection by other identical or closely related viruses. Shortly after infection by bacteriophage T5, the bacterium Escherichia coli produces Llp, encoded by the newly injected viral genome. Llp is a small lipoprotein targeted to the inner leaflet of the host outer membrane. It binds to FhuA, an outer-membrane iron-ferrichrome transporter, which is the T5 receptor at the E. coli cell surface. The interaction between Llp and FhuA prevents any further bacteriophage binding and infection. Here, we determined the NMR structure of Llp and analyzed the formation of the FhuA:Llp complex using a wide range of techniques and mutants, both in vivo and in vitro . Interaction of Llp with FhuA is governed by a two-step equilibrium with a strong contribution of induced fit: Llp binding requires remodeling of FhuA periplasmic plug surface, enabling the subsequent large conformational reorganization of the extracellular loops. Analysis of FhuA mutants shows the importance of the intertwined interactions between the extracellular loops and the plug in the communication between the periplasmic and the extracellular faces of FhuA. IMPORTANCE: Bacteriophages (phages) are viruses that infect bacteria. As their enemies, phages play an important role in the dynamics, diversity, evolution, and pathogenicity of bacterial populations, but also represent an alternative to antibiotics in our fight against the rise of multi-resistant pathogenic bacterial strains. Infection is triggered by phage recognition of a receptor at the host surface, inducing phage DNA injection into the bacterial cytoplasm. The host cell is then transformed into a viral factory. To secure this viral factory, the infecting phage develops superinfection exclusion strategies, preventing other phages from interfering. Understanding how phages achieve the “locking” of the host will allow us to optimize phage use in phage therapy. Here, we analyze the structure of the receptor-exclusion protein complex using integrated in vivo , biochemical, and biophysical approaches. Our analysis reveals an unusually slow association process, consistent with an induced-fit mechanism, ultimately transmitting information from the bacterial periplasm to its surface.

28 March 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
SDSéraphine Degroux
Séraphine Degroux
CDCorinne Deniaud-Vivès
Corinne Deniaud-Vivès
EMEmeline Metsdach
Emeline Metsdach
CDClaudine Darnault
Claudine Darnault
ARAline le Roy
Aline le Roy
CBCécile Breyton
Cécile Breyton
Superinfection exclusion is a widespread viral mechanism that protects the infected cell from over infection by other, identical or closely related viruses. Shortly after infection by bac-teriophage T5, the bacterium E. coli produces Llp coded by the just injected viral genome. Llp is a small lipoprotein targeted to the inner-leaflet of the host outer-membrane. It binds to FhuA, an outer-membrane iron-ferrichrome transporter, which is T5 receptor at the E. coli cell surface. The interaction between Llp and FhuA prevents any further bacteriophage binding and infection. Here, we determined the RMN structure of Llp and analyse the formation of the FhuA:Llp complex using a wide range of techniques and mutants, both in vivo and in vitro . Interaction of Llp to FhuA is governed by a two-step equilibrium with a strong contribution of induced fit: Llp binding requires remodelling of FhuA periplasmic plug surface, allowing the further large conformational reorganisation of the extracellular loops. Analysis of FhuA mu-tants show the importance of the intertwined interactions between the extracellular loops and the plug in the communication between the periplasmic and the extracellular faces of FhuA.

12 February 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
JMJacopo Manigrasso
Jacopo Manigrasso
EMEmeline Mestdach
Emeline Mestdach
RQRiccardo Quaia
Riccardo Quaia
DDDaniela Dankova
Daniela Dankova
MBMattias Bood
Mattias Bood
GSGiuseppina La Sala
Giuseppina La Sala
Small molecules that target precursor microRNAs (pre-miRNAs) offer a strategy to modulate microRNA biogenesis, but rational design is limited by the intrinsic conformational dynamics of RNA. Here, we combine site-specific nuclear magnetic resonance (NMR) spectroscopy with enhanced-sampling molecular dynamics (MD) simulations to define the conformational ensemble of pre-miR-377 and its recognition by the small-molecule binder C1. Our data reveals that the Dicer cleavage site contains a dynamic adenosine bulge in which U25 shuffles between A3 and A4 with a ∼9:1 population ratio, generating two interconverting RNA triple structures. NMR-informed MD and binding simulations show that C1 engages this dynamic region through a pathway-dependent mechanism that favors minor-groove entry, stabilizes intermediate, partially reorganized Dicer-site conformations, and redistributes the conformational ensemble away from processing-competent states. A conformationally locked mutant abolishes binding, indicating that recognition depends on bulge-enabled RNA dynamics rather than a single static structure. These results define the structural and dynamic basis of small-molecule recognition at the pre-miR-377 Dicer site and highlight the importance of RNA conformational ensembles in RNA-targeted drug discovery.